EHTH Q1 Earnings Call: Revenue Growth, Margin Expansion, and Regulatory Developments Shape Outlook

Online health insurance comparison site eHealth (NASDAQ:EHTH) announced better-than-expected revenue in Q1 CY2025, with sales up 21.7% year on year to $113.1 million. The company expects the full year’s revenue to be around $530 million, close to analysts’ estimates. Its non-GAAP loss of $0.27 per share was 38.1% above analysts’ consensus estimates.

Is now the time to buy EHTH? Find out in our full research report (it’s free).

StockStory’s Take

eHealth’s first quarter performance was shaped by significant Medicare enrollment activity and continued optimization of its sales and marketing operations. CEO Fran Soistman highlighted a 22% increase in Medicare submissions, emphasizing the impact of targeted marketing and enhanced telephonic and online conversion rates. The company attributed margin improvement to efficiency gains and lower acquisition cost per approved member, despite doubling the size of its retention and customer service team. Management also referenced the positive effects of omnichannel capabilities and a brand strategy resonating with Medicare beneficiaries. The integration of AI into the telephonic enrollment process and robust cash collections from new enrollments contributed to profitability gains. Soistman noted, “Our omnichannel marketplace empowered hundreds of thousands of Medicare beneficiaries to explore their coverage choices, a complicated and highly consequential decision.”

Looking ahead, eHealth’s guidance is grounded in an evolving regulatory landscape and shifting Medicare Advantage reimbursement rates. Management pointed to the finalization of new Medicare rules and increased carrier reimbursement rates as important developments for the industry, while remaining cautious about predicting the impact on the next enrollment period. Soistman stated, “While we have seen positive early signs of the Medicare macro environment thus far in the year, it is too early to tell how this upcoming enrollment cycle... will compare to last year’s.” The company identified new-to-Medicare enrollments and regulatory changes around special needs plans as key focus areas for the next two quarters. eHealth also addressed the recent Department of Justice complaint, affirming its intent to defend its practices and emphasizing no current impact on operations or carrier relationships. These factors, along with further investments in technology and brand development, are expected to shape the trajectory for the remainder of the year.

Key Insights from Management’s Remarks

Management attributed strong quarterly results to Medicare enrollment growth, cost efficiencies, and the integration of new technology, while also addressing evolving regulatory and legal developments.

• Medicare enrollment momentum: eHealth achieved 22% growth in total Medicare submissions, driven by targeted marketing campaigns and improvements in both telephonic and online conversion rates. The company’s omnichannel approach, including hybrid online-agent enrollments, saw particularly high growth, reflecting consumer demand for flexible shopping and advisory options.

• Operational efficiency gains: Despite nearly doubling the size of the retention and customer service team, acquisition cost per approved Medicare member declined by 10% year over year. This was credited to a greater proportion of leads from direct branded channels and ongoing process improvements in customer acquisition and retention efforts.

• Technological advancements: eHealth initiated a pilot program integrating artificial intelligence into its telephonic enrollment process. Early results indicate the technology provides valuable after-hours support and reduces wait times during peak enrollment periods. Management plans further investment in AI capabilities ahead of the annual enrollment period (AEP).

• Regulatory clarity and industry environment: The company welcomed recent final Medicare Advantage and prescription drug plan rules, as well as higher-than-anticipated carrier reimbursement rates for 2026. Leadership views these developments as supportive for both brokers and beneficiaries but noted it is premature to forecast the impact on next cycle’s commission rates and plan offerings.

• Legal and compliance update: Management addressed the Department of Justice complaint regarding industry practices, stating the company is fully cooperating and believes the claims are without merit. They reported no change in operations or carrier relationships as a result, and no litigation reserve has been recorded.

Drivers of Future Performance

Management expects future performance to be shaped by regulatory developments, Medicare enrollment trends, and ongoing investments in technology and brand initiatives.

• Regulatory changes and reimbursement rates: eHealth anticipates that new Medicare Advantage rules and updated carrier reimbursement rates will influence plan offerings, beneficiary shopping activity, and broker commission structures in the next enrollment cycle. However, leadership remains cautious, noting that the full effect will not be clear until carrier bids and CMS commission rates are finalized in coming months.

• Enrollment seasonality and member retention: Changes in dual special needs plan (D-SNP) enrollment rules are expected to create year-over-year headwinds in the second and third quarters. Management is focused on capturing new-to-Medicare customers and improving retention, particularly among members who switch plans but remain with eHealth. Early indicators suggest improved recapture rates, though full retention metrics will be available later in the year.

• Technology and brand investments: The company continues to invest in AI-powered enrollment tools, omnichannel platform enhancements, and expanded brand campaigns. These initiatives are intended to support advisor productivity, increase consumer trust, and drive higher conversion rates during critical enrollment periods. Management believes these efforts will help differentiate eHealth in a competitive landscape.

Catalysts in Upcoming Quarters

Going forward, the StockStory team will be monitoring (1) the pace of Medicare enrollment growth, especially among new-to-Medicare beneficiaries during off-cycle periods; (2) the impact of regulatory and reimbursement changes on plan availability, consumer behavior, and broker commissions; and (3) any developments related to the Department of Justice investigation and its effect on carrier relationships. Progress in technology deployment and brand expansion will also be important markers of effective execution.

eHealth currently trades at a forward EV/EBITDA ratio of 2.7×. Is the company at an inflection point that warrants a buy or sell? Find out in our full research report (it’s free).

Our Favorite Stocks Right Now

Market indices reached historic highs following Donald Trump’s presidential victory in November 2024, but the outlook for 2025 is clouded by new trade policies that could impact business confidence and growth.

While this has caused many investors to adopt a "fearful" wait-and-see approach, we’re leaning into our best ideas that can grow regardless of the political or macroeconomic climate. Take advantage of Mr. Market by checking out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.